Press Release Distribution
 

Members Login  |  Register  |  Why Join?   Subscribe to Newsletter Newsletter   RSS Feeds RSS Feeds

Video Releases    |    Pricing & Distribution Plans    |    Today's News    |    News By Category    |    News By Date    |    Business Directory
All Press Releases for October 24, 2012 »
RSS Feeds RSS Feed     Print this news Printer Friendly     Email this news Email It    Create PDF PDF Version   



Texas Attorneys Launch New Resource for Corporate, Government Whistleblowers
Members of the legal team that won the largest Medicaid fraud settlement in Texas history have launched a new online resource to help corporate and government whistleblowers. 
x-small text small text medium text large text


    DALLAS, TX, October 24, 2012 /24-7PressRelease/ -- Winning team in Texas' largest Medicaid whistleblower settlement debuts new website

A team of Texas attorneys with decades of courtroom experience has launched the new website Texas Whistleblower (http://www.txwhistleblower.com) to assist government employees and those at private and publicly-traded companies who stand to claim significant financial rewards for reporting unethical business practices by their employers.

Dallas attorneys Tom Melsheimer and Natalie Arbaugh and Austin lawyer Tommy Jacks recently established the Texas Whistleblower website in response to increasing demand for information on U.S. whistleblower laws and the money available for those employees who recognize and report ethical breaches in the workplace.

"Whistleblower laws date back to the Civil War, where they protected the Union Army from being ripped off by unscrupulous providers of supplies. Today, these laws help combat fraud involving federal and state programs and other misconduct by corporations," says Mr. Melsheimer. "We believe the Texas Whistleblower website will be a valuable resource for employees who want to know more about whistleblower laws, and those who are considering reporting something they already may have witnessed where they work."

In January, Mr. Melsheimer, Ms. Arbaugh and Mr. Jacks worked with the Texas Attorney General's Office to secure a $158 million settlement for whistleblower Allen Jones and the State of Texas against pharmaceutical manufacturer Johnson & Johnson and its Janssen unit. The settlement was reached during a trial that accused the defendants of using misleading marketing tactics to convince Texas officials to spend millions on the anti-psychotic drug Risperdal. The settlement amount is nearly double the largest Medicaid fraud settlement in Texas history.

"New whistleblower laws, such as those in the Dodd-Frank Act, and the money awards offered by the U.S. Securities and Exchange Commission (SEC) have created a new dynamic in the courts for employees who step forward and reveal their employers' misdeeds," says Mr. Jacks. "We're staying abreast of the latest developments in whistleblower laws in order to benefit clients from the start of the process all the way through trial."

Texas Whistleblower serves as a resource for employees who decide to file whistleblower claims. The site includes informative videos with a "behind the scenes" perspective, answers to frequently-asked questions, and information about whistleblower rights and protections.

For more information on the Texas Whistleblower website, please contact Bruce Vincent at 800-559-4534 or bruce@androvett.com.


---
Press release service and press release distribution provided by http://www.24-7pressrelease.com


# # #

Read more Press Releases from Bruce Vincent:


Contact Information:
Bruce Vincent
Androvett Legal Media

Dallas, TX
USA
Voice: 800-559-4534
E-Mail: Email us Here
Website: Visit Our Website
Disclaimer:
If you have any questions regarding information in this press release, please contact the person listed in the contact module of this page. Please do not attempt to contact 24-7PressRelease. We are unable to assist you with any information regarding this release. 24-7PressRelease disclaims any content contained in this press release. Please see our complete Terms of Service disclaimer for more information.